A detailed history of Signaturefd, LLC transactions in Senseonics Holdings, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 1,250 shares of SENS stock, worth $400. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,250
Previous 1,250 -0.0%
Holding current value
$400
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$0.5 - $0.73 $2 - $2
-4 Reduced 0.32%
1,250 $0
Q4 2023

Jan 31, 2024

SELL
$0.48 - $0.7 $6,240 - $9,100
-13,000 Reduced 91.2%
1,254 $0
Q2 2023

Aug 01, 2023

BUY
$0.55 - $0.89 $2 - $3
4 Added 0.03%
14,254 $10,000
Q1 2023

Apr 28, 2023

SELL
$0.68 - $1.25 $4,760 - $8,750
-7,000 Reduced 32.94%
14,250 $10,000
Q4 2022

Jan 27, 2023

SELL
$0.96 - $1.34 $461 - $644
-481 Reduced 2.21%
21,250 $21,000
Q3 2022

Nov 08, 2022

BUY
$1.02 - $2.23 $490 - $1,072
481 Added 2.26%
21,731 $29,000
Q2 2022

Aug 10, 2022

BUY
$0.94 - $1.94 $940 - $1,940
1,000 Added 4.94%
21,250 $22,000
Q1 2022

May 02, 2022

BUY
$1.54 - $3.71 $1,540 - $3,710
1,000 Added 5.19%
20,250 $40,000
Q4 2021

Jan 25, 2022

BUY
$2.58 - $3.91 $3,870 - $5,865
1,500 Added 8.45%
19,250 $51,000
Q3 2021

Oct 28, 2021

BUY
$2.77 - $4.05 $872 - $1,275
315 Added 1.81%
17,750 $60,000
Q2 2021

Jul 26, 2021

BUY
$1.71 - $4.14 $7,583 - $18,360
4,435 Added 34.12%
17,435 $67,000
Q1 2021

Apr 30, 2021

BUY
$0.85 - $5.27 $5,100 - $31,619
6,000 Added 85.71%
13,000 $34,000
Q2 2020

Jul 30, 2020

BUY
$0.39 - $0.69 $780 - $1,380
2,000 Added 40.0%
7,000 $3,000
Q1 2020

Apr 23, 2020

BUY
$0.56 - $1.62 $1,816 - $5,253
3,243 Added 184.58%
5,000 $3,000
Q1 2018

May 08, 2018

BUY
$2.48 - $3.21 $4,357 - $5,639
1,757 New
1,757 $5,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $149M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.